Riya Drugs Private Limited - Company Profile

It is a trading private limited company based in Surat, Gujarat, India, established in 2015.
2015 Surat, Gujarat, India Active
Last Updated:
Access Report
About Riya Drugs Private Limited

Riya Drugs Private Limited, a active private limited company, was established on 29 September 2015 in Surat, Gujarat, India. Engaging in retail trading within the trade sector, it holds CIN: U24232GJ2015PTC084609. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Keyurkumar Manilal Patel (Director), Kirtikumar Manilal Patel (Director), Jayeshkumar Atmarambhai Patel (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 25, Shree Rancchodrai Nagar Ind Estate, Nr. Surat Raktadan, Udhana-Magdalla Road, Surat, Gujarat, 395002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232GJ2015PTC084609

  • Registration Number

    084609

  • Incorporation Date

    29 September 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 65.82%
  • Profit Growth **** 0.41%
  • Ebitda **** 0.43%
  • Net Worth 7.61%
  • Total Assets **** 37.13%
Company report

Riya Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Riya Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Riya Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Keyurkumar Manilal Patel Director 29 Sep 2015 Current
Kirtikumar Manilal Patel Director 29 Sep 2015 Current
Jayeshkumar Atmarambhai Patel Director 29 Sep 2015 Current
Sangita Jayeshkumar Patel Director 29 Sep 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Riya Drugs.

Riya Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 65.82% increase. The company also saw a slight improvement in profitability, with a 0.41% increase in profit. The company's net worth moved up by a moderate rise of 7.61%.

Riya Drugs revenue growth over time
Riya Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 65.82%
*******
*******
*******
*******
Revenue from Operations
*******
 65.82%
*******
*******
*******
*******
Total Assets
*******
 37.13%
*******
*******
*******
*******
Profit or Loss
*******
 0.41%
*******
*******
*******
*******
Net Worth
*******
 7.61%
*******
*******
*******
*******
EBITDA
*******
 0.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Riya Drugs?

In 2022, Riya Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Riya Drugs?

Unlock and access historical data on people associated with Riya Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Riya Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riya Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Riya Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Riya Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Riya Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Progress on Keyurkumar Manilal Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 5 months . was documented.

  • Director Appointment

    Progress on Kirtikumar Manilal Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 5 months . was documented.

  • Director Appointment

    The activity Jayeshkumar Atmarambhai Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 5 months . was completed.

  • Director Appointment

    The activity Sangita Jayeshkumar Patel was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Riya Drugs Private Limited?

The CIN of Riya Drugs Private Limited is U24232GJ2015PTC084609.

Where is Riya Drugs Private Limited headquartered?

Riya Drugs Private Limited is headquartered at Plot No. 25, Shree Rancchodrai Nagar Ind Estate, Nr. Surat Raktadan, Udhana-Magdalla Road, Surat, Gujarat, 395002.

When was Riya Drugs Private Limited incorporated?

Riya Drugs Private Limited was incorporated on 29 September 2015.

Who are the current directors of Riya Drugs Private Limited?

The current directors of Riya Drugs Private Limited are

What is the primary industry of Riya Drugs Private Limited?

The primary industry of Riya Drugs Private Limited is Trade.

Is Riya Drugs Private Limited a listed company?

Riya Drugs Private Limited is unlisted.

What is the capital structure of Riya Drugs Private Limited?

The authorized capital of Riya Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Riya Drugs Private Limited?

The compliance status of Riya Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available